Blood Cancer Talks cover image

Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma

Blood Cancer Talks

00:00

The Differences Between NIVO AVD and Breakad

There was no difference in the incidence of febron the droppenia or infections between those two. The biggest change was actually the need for transfusions and so significantly fewer patients had red blood cell and platelet transfusions even on breakad. That's almost unheard of with NIVO AVD certainly a platelet transfusion would never be needed. I think it's much it seems better than BICOP and four cycles certainly seems better than six but it's still more toxic than VV-AVD and more toxic than NEBO-AVD  and is 95% different at three years from 94% at one year maybe.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app